KRAS and lung carcinoma: We further confirmed this observation in 2 Kras-driven genetically engineered mouse models of lung cancer: the Lox-Stop-Lox-KrasG12D (KrasLSL-G12D/+) mouse strain and the KrasLSL-G12D/+p53fl/fl mouse strain (21, 22).